KAITLYN SPRAGUE: Open Payments
NPI 1073009353 · WEST PALM BEACH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,007 in 46 payments from 10 companies in 2025. Trend: 2023 $265 · 2024 $113 · 2025 $1,007
Food & beverage: $1,007
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $254 |
| ABBVIE INC. | 7 | $146 |
| Teva Pharmaceuticals USA, Inc. | 6 | $114 |
| Neurocrine BioSciences, Inc. | 3 | $100 |
| Axsome Therapeutics, Inc. | 5 | $98 |
| Alkermes, Inc. | 5 | $92 |
| Janssen Pharmaceuticals, Inc | 4 | $84 |
| Otsuka America Pharmaceutical, Inc. | 3 | $80 |
| Vanda Pharmaceuticals Inc. | 1 | $25 |
| Lundbeck LLC | 1 | $14 |
Products named: CAPLYTA, VRAYLAR, AUSTEDO XR, INGREZZA, Auvelity, REXULTI, ARISTADA, INVEGA SUSTENNA.
Industry payments across FL — which companies pay providers there.
